Publication

Article

BioPharm International

BioPharm International-08-15-2014
Volume2014 eBook
Issue 2

The Challenge of Finding the Unknown

Author(s):

Cynthia A. Challener

Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.

 

Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.

 

Read this article

from BioPharm International’s 2014 Analytical and Bioanalytical eBook.

 

 

 

 

 

Articles in this issue
BPsupp0814_Method_TransferR1_200.jpg
Keys to Successful Method Transfer
BPsupp0814_Viral_Contam_200.jpg
The Challenge of Finding the Unknown
BPsupp0814_SGSR1_200.jpg
Testing the Quality, Safety, and Efficacy of Insulin Biosimilars
BPsupp0814_biorad_200.jpg
Using the Purity Quotient Difference to Assess Protein Purification
BPsupp0814_Allotrope_200.jpg
Standardizing Data Management

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
PRAGUE, CZECHIA - NOVEMBER 1, 2019: Astellas logo in front of their main office for Prague. Astellas Pharma is a Japanese Pharmaceutical company spread worldwide | Image Credit: © Jerome - stock.adobe.com
August 21st 2025

Astellas and Pfizer Bladder Cancer Therapy Recommended by UK’s NICE

Patrick Lavery
The front of the REGENXBIO facility in Rockville, Montgomery County, Maryland. REGENXBIO is a biotechnology company researching Adeno-Associate Virus (AAV) gene therapy | Image Credit: © MJ Kerr - stock.adobe.com
August 21st 2025

FDA Extends Review Period for REGENXBIO Hunter Syndrome Treatment

Patrick Lavery
Lung cancer, 3D illustration and photo under microscope. Histopathology light micrograph of small cell lung cancer | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
August 21st 2025

Merck and Daiichi Sankyo’s I-DXd Earns FDA Breakthrough Therapy Status in Small Cell Lung Cancer

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 21st 2025

FDA Grants Breakthrough Therapy Designation to Bispecific ADC for EGFR-Mutant Lung Cancer

Feliza Mirasol
Human papillomavirus infection. Virus. HPV is the most common sexually transmitted infection globally. HPV infection is caused by human papillomavirus, a DNA virus from the papillomavirus family, 3d | Image Credit: © Naeblys - stock.adobe.com
August 21st 2025

FDA Approves Precigen’s Immunotherapy to Treat Recurrent Respiratory Papillomatosis

Patrick Lavery
Quality Control Laboratory medicine. Chromatograph operation. A woman makes an analysis on a gas chromatograph. Development of a new vaccine against the covid-19 virus. | Image Credit: © neznamov1984 - © neznamov1984 - stock.adobe.com
August 21st 2025

ElevateBio BaseCamp Achieves First Multi-Modality ICMC Certification in Commercial CGT Manufacturing

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.